Top ClinOne Alternatives

Clin'form is a robust and flexible electronic Clinical Outcome Assessment (eCOA) platform designed to enhance the efficiency of clinical trials for both participants and research facilities, while also improving data accuracy and expediting processes for research teams. Its adaptability allows it to be utilized across a wide array of protocols and demographics, making it ideal for any questionnaire type, including Patient-Reported Outcomes (PRO), Observer-Reported Outcomes (ObsRO), Clinician-Reported Outcomes (ClinRO), and diaries, catering to a diverse demographic from children to seniors. The platform is engineered to accommodate varying population sizes, effectively managing studies that involve small cohorts as well as those with more than 10,000 participants across multiple global locations. Clin'form seamlessly integrates with other clinical systems to create an efficient workflow, supporting a range of data collection methods—including dedicated tablets, smartphones, patients' personal devices, web access via any browser, and in-person interviews. A standout feature is the integrated tele-visit option, which provides flexibility in response to unforeseen changes, along with patient engagement tools that are designed to foster high compliance rates. Furthermore, the intuitive interface of Clin'form ensures that both researchers and participants can navigate the platform with ease, thereby enhancing the overall clinical trial experience and effectiveness. Overall, Clin'form not only streamlines the data collection process but also places a strong emphasis on user experience, making it a valuable asset in clinical research.

Since 2005, Medrio's Electronic Data Capture (EDC) platform and its complementary eClinical solutions like ePRO, RTSM, eConsent, and Direct Data Capture (DDC) have gained the trust of leading pharmaceutical, biotech, CRO, animal health, medical device, and diagnostic organizations. Our reputation is built on providing user-friendly solutions that enhance the efficiency and simplicity of clinical trials across all phases, sizes, and complexities. Users of Medrio can create their databases in an average of 2.8 weeks without needing any programming skills and can easily implement mid-study modifications with just a few clicks. With options ranging from add-on features to comprehensive service packages, Medrio delivers adaptable, modular solutions tailored to meet the precise needs of our clients, ensuring they receive only the services they require. Our cutting-edge software, combined with extensive training and support resources, has resulted in a remarkable 98% customer satisfaction rating, demonstrating our commitment to excellence in the clinical trial landscape. We continuously strive to innovate and improve our offerings to keep pace with the evolving needs of our users.

WCG ClinSphere introduces a revolutionary approach to executing thorough clinical trials. By utilizing artificial intelligence, this innovative platform connects sites, sponsors, CROs, and participants all within a unified cloud-based framework. It serves as a central hub for managing your trial from the very beginning to the end. The design of WCG ClinSphere rests on four core principles that enhance its overall efficiency. Our comprehensive clinical dataset underpins a federated AI learning model, promoting intelligent automation throughout the clinical trial lifecycle. Users benefit from the availability of real-time reports and insights, enabling them to stay informed and make swift decisions. The platform streamlines tasks and boosts precision through user-friendly workflows that offer assistance at each phase. Additionally, it enhances logistics, operations, and processes throughout the clinical research journey, resulting in quicker and more effective outcomes. By combining extensive data resources with sophisticated analytics, WCG ClinSphere cultivates the vital connections necessary for speeding up clinical research progress. Moreover, the platform's collaborative environment promotes ongoing innovation and improvement in trial management, ensuring that stakeholders can adapt to new challenges effectively. Overall, WCG ClinSphere represents a significant step forward in the evolution of clinical trial management.

5thPort serves as a digital platform for eConsent, patient engagement, and education, suitable for use in individual practices, hospitals, healthcare systems, and clinical research environments. By employing high-quality, prescriptive media along with the teach-back method, it effectively informs patients and caregivers about their diagnoses, treatment plans, and the associated risks and benefits. The platform's digital eConsent feature promotes meaningful dialogues between patients and healthcare providers after patients have been thoroughly educated. Implementing 5thPort can lead to the following benefits: it can save practitioners 15 to 20 minutes per consultation without requiring extra effort, improve the overall patient experience, alleviate anxiety on appointment days, foster active patient participation in healthcare discussions, and help decrease nurse burnout. With these advantages, 5thPort not only enhances the quality of care but also supports healthcare professionals in managing their workload more effectively.

Antidote acts as a recruitment hub for clinical trials, accelerating the pace of medical research by linking patients with sponsors through specialized recruitment services and an intuitive matching search engine. To combat the issue where over 80% of clinical trials experience setbacks from a lack of participants, Antidote provides sponsors with a centralized, vendor-neutral dashboard that streamlines referrals from various sources, automates the outreach for due diligence and owner letters, and tracks enrollment and return on investment metrics in real time, while delivering valuable analytics on sites and candidates with updates every hour. For patients, Antidote’s smart matching system transforms complex inclusion and exclusion criteria into simple guided Q&A interactions, ultimately presenting them with current clinical trial listings and tailored notifications for new matching opportunities. The platform is built to support both bulk and individual record imports, complete with automated validations, and it boasts user-friendly, multilingual interfaces that are optimized for mobile devices. By simplifying the recruitment process, this innovative solution promotes more effective collaboration between researchers and potential participants, ultimately leading to improved outcomes in clinical studies. Moreover, Antidote’s commitment to accessibility ensures that a diverse range of patients can easily engage with clinical trials, thereby enriching the research landscape.

PicnicHealth acts as a vital link connecting patients to researchers by delivering targeted and thorough real-world data. By collaborating with patients who voluntarily provide their medical histories for research, we can cultivate a rich understanding of patient health that includes insights from all healthcare providers rather than being confined to a single location or specialist. Our network of established patient communities, along with effective recruitment strategies through various direct-to-patient avenues, facilitates the easy assembly of the appropriate patient cohort. Patients can swiftly register and consent in just ten minutes, enabling them to access their medical records. If you have patients participating in ongoing registries or clinical trials, consider recommending PicnicHealth for a more efficient setup process. Our research platform is crafted to deliver customized real-world data at the individual patient level, allowing researchers to specify exactly which data elements, including doctors’ notes and narrative text, should be extracted from medical records. This innovative, patient-centric methodology not only amplifies the quality of the data collected but also motivates patients to engage actively in the research journey. By fostering this empowerment among patients, we aim to cultivate a more profound understanding of health outcomes, ultimately elevating the quality and relevance of research conducted in the field. Furthermore, this collaboration has the potential to inspire a greater sense of ownership among patients regarding their health information, leading to more robust participation in future studies.

Replior stands out as an innovative company that focuses on delivering advanced software solutions tailored for clinical trials, featuring a comprehensive platform that integrates EDC, eConsent, ePRO, and Virtual Visits to optimize trial execution. Our all-encompassing system, known as Trial Online, streamlines the collection and management of data from researchers, participants, and wearable technology efficiently. It is meticulously designed to support decentralized clinical trials (DCT), providing the flexibility to accommodate site visits, remote interactions, or a blend of both. Our journey began two decades ago when we were tasked with developing an online CRF service for a prominent pharmaceutical company, which marked our evolution from an IT operations provider into a specialized software developer focused on clinical data collection. Over time, we have broadened our offerings to provide a full range of data collection services, while our IT operations are adeptly overseen by our highly skilled sister company, Complior. As we forge ahead, our unwavering commitment to innovating and improving clinical trial processes remains central to our purpose, driving us to continually enhance user experience and data integrity in the trials we support.

ClinEdge is transforming the landscape of clinical trials by providing a comprehensive suite of services tailored for Sponsors, CROs, and Sites. We utilize innovative and collaborative strategies to tackle the various challenges our clients face throughout the process. Our unwavering commitment to improving trial outcomes encompasses all phases of each study, ensuring that both Sponsors and CROs benefit from enhanced Site and Patient Access, while also delivering superior Trial Solutions to our Site partners. With over a decade of experience in the industry and a deep understanding of our clients' needs, ClinEdge is dedicated to redefining how studies are executed, ultimately leading to more efficient and effective clinical trials. Our goal is not only to innovate but also to establish new benchmarks within the clinical trial industry, fostering a culture of excellence and reliability. As we continue to grow and adapt, we remain focused on delivering exceptional value to our partners and stakeholders.

Trialbee's Honey Platform transforms the landscape of global patient recruitment by bringing all referrals together into a single, vendor-neutral dashboard, which guarantees consistency in data across various recruitment partners while providing actionable insights and visual metrics for return on investment for each collaborator. The Precision Recruitment module develops patient profiles based on data, supports live medical secondary screenings, and employs highly-targeted digital outreach strategies to pinpoint and engage the most suitable candidates. Furthermore, the Omnichannel Solutions leverage a meticulously assembled network of community advocates, pharmacies, labs, and other reliable partners, all of which are integrated and transparently managed within Honey, to enhance access to diverse patient demographics. By offering real-time analytics and thorough ROI reporting, trial operations teams receive vital guidance for success and actionable insights, thereby simplifying complex compliance requirements and refining enrollment strategies within a single, user-friendly SaaS platform. This cutting-edge methodology not only streamlines processes but also cultivates a more inclusive atmosphere for patient recruitment across various communities, ultimately leading to improved health outcomes for underrepresented groups. In doing so, it significantly contributes to the advancement of equitable healthcare access for all.

Signant Health stands as a global frontrunner in evidence generation, dedicated to revolutionizing the clinical trial landscape by engaging patients in their own settings and reimagining the path to validation. They provide a comprehensive suite of clinical technology solutions that encompasses electronic Clinical Outcome Assessments (eCOA), Electronic Data Capture (EDC), electronic clinician evaluations, and an integrated eClinical platform. Their offerings also include patient engagement tools like an intuitive app, eConsent for effective informed consent practices, and telehealth capabilities. Furthermore, Signant Health specializes in clinical data and analytics services, which involve COA data analysis along with the synthesis and interpretation of data. With over thirty years of experience, the company has been crucial in facilitating numerous clinical trials and has significantly contributed to hundreds of drug approvals, solidifying their position as a dependable partner for sponsors and CROs who aim to deliver high-quality data for informed decision-making and regulatory filing. Their unwavering dedication to innovation is continuously molding the future of clinical research, ensuring that advancements benefit both patients and the medical community at large.

Studypages functions as a comprehensive clinical trial management platform designed to enhance the overall experience for participants while streamlining clinical processes. It offers an array of tools that facilitate participant engagement, site management, sponsor oversight, seamless communication, collaboration, and the automation of workflows. By consolidating these functionalities into one platform, Studypages markedly increases the efficiency and productivity of clinical research, which accelerates the progression of medical innovations. Furthermore, this unified approach ensures that every stakeholder remains connected and well-informed during the entire research journey, fostering transparency and collaboration. Such alignment is crucial for the successful execution of trials and the realization of their outcomes.

AutoCruitment presents a cutting-edge, online platform that establishes a direct link with patients, facilitating the efficient recruitment, qualification, and automatic direction of the most appropriate candidates to clinical trials. By employing state-of-the-art global recruitment technologies, it simplifies the search, screening, and referral processes for patients, eliminating the conventional obstacles associated with provider consent, access to medical records, and investigator site involvement. Through advanced online behavior analysis and geotargeting across a network of more than 1,500 digital channels—including search engines, display advertisements, social media platforms, and mobile collaborations—it adeptly reaches and pre-qualifies patients in real-time, utilizing customized online screening tools that meet specific inclusion and exclusion criteria. Research institutions gain access to a secure and user-friendly portal that offers instant referrals, customizable reporting capabilities, and live-tracking dashboards for enhanced oversight. Moreover, specialized teams for project management and site engagement work in tandem to boost randomization rates, which ultimately leads to a more streamlined trial process overall. This holistic method not only enhances patient recruitment but also cultivates deeper connections between research sites and potential trial participants, thereby enriching the overall clinical research landscape. Ultimately, the platform's innovative approach positions AutoCruitment as a leader in the realm of clinical trial recruitment.

A reliable and intuitive cloud-based Electronic Data Capture (EDC) platform designed to oversee clinical trials and studies, regardless of their scale or complexity, encompassing features like electronic patient-reported outcomes (ePRO), electronic consent (eConsent), electronic clinical outcome assessments (eCOA), electronic source data (eSource), patient-reported outcome measures (PROMs), patient-reported experience measures (PREMs), functional health assessments, and tools for participant education and engagement. This versatile platform enhances the efficiency of research processes, ensuring that both researchers and participants have a seamless experience throughout the study.

Jeeva has developed a revolutionary modular system that operates on a cutting-edge cloud platform. With just one login from any device that supports a browser, users can easily screen patients, offer education, manage enrollment, send SMS and emails, and compile evidence such as electronic patient-reported outcomes. Frustrations with slow patient recruitment and retention are common in the industry, making it imperative to gather solid evidence of safety and efficacy for new investigational medicines to secure approval from regulatory agencies. Jeeva stands out as an invaluable resource for optimizing time and financial resources for patients and biopharma sponsors, particularly in long-term follow-up studies associated with gene therapy. Its innovative approach streamlines processes, ultimately enhancing the efficiency of clinical trials and improving patient care.

In the past, clinical trials and medical research were typically conducted in isolation from the everyday care provided by local healthcare providers and individual practitioners. As a result, many doctors were often unaware of the research efforts underway, leaving their patients in the dark about potential studies that could improve their health outcomes. Elligo has revolutionized this scenario by enabling greater involvement in clinical research through access to an extensive network of over 150 million patients and their detailed data, which allows physicians to introduce research opportunities to patients who might not have otherwise been aware of them. The conventional participant recruitment methods frequently encounter obstacles, including the necessity for patients to travel to designated research locations, which can hinder participation rates. Furthermore, research suggests that patients are more likely to engage in studies when these initiatives are associated with their familiar healthcare providers, highlighting the critical need for the integration of clinical research within established medical settings. By adopting this innovative approach, not only do we bridge the divide between research and patient care, but we also empower individuals to actively engage in meaningful medical advancements that could potentially change their lives. This integration fosters a collaborative environment where patients feel more supported and informed about their treatment options.

Longboat is a cloud-based platform tailored to enhance the efficiency of clinical trials, featuring an integrated Guided Compliance toolset that provides ongoing assistance to users throughout the entire process. By equipping clinical trial site personnel with vital resources, Longboat allows them to focus more on patient care. Moreover, participants can conveniently access important study information and receive timely reminders for upcoming visits. The system streamlines the management of protocol amendments, ensuring they are implemented smoothly and effectively. Additionally, Longboat centralizes the secure exchange of regulated documents among sponsors, CROs, and sites, thereby significantly improving the startup process and alleviating the burden of traditionally tedious tasks for all involved in research. With a unified support platform, all primary stakeholders—including clinical operations teams, monitors, site staff, and trial participants—can access tailored content that meets their specific needs. This holistic strategy guarantees that site staff are well-equipped with the necessary tools and resources to stay engaged and compliant while maintaining a strong focus on participant welfare. In this manner, Longboat not only enhances operational efficiency but also significantly enriches the overall experience for everyone participating in the clinical trial, fostering a more collaborative and effective research environment. By prioritizing user needs, Longboat paves the way for innovative solutions in clinical research management.

Clinion eCOA facilitates the execution of decentralized clinical trials, enabling patients to participate from the comfort of their own homes. With the use of their smartphones, study participants can conveniently report their health status, allowing healthcare professionals to monitor them in real time. The integration of Clinion eCOA with Clinion EDC ensures that trial participants can enter daily outcomes directly into the system, effectively reducing issues related to data duplication and transcription errors while granting clinicians a continuous overview of patient progress. Additionally, the eCOA app supports multilingual forms, enhancing patient engagement and resulting in cleaner data collection. This decentralized approach not only streamlines the recruitment process but also accelerates patient enrollment, broadening the reach of clinical trials significantly. Overall, Clinion eCOA represents a pivotal advancement in the efficiency and effectiveness of clinical research.

Suvoda stands as a prominent player in the arena of clinical trial technology, concentrating on complex, life-saving research in areas such as oncology, central nervous system disorders, and rare diseases. Founded in 2013, the organization offers a robust platform equipped with Interactive Response Technology (IRT), electronic Consent (eConsent), electronic Clinical Outcome Assessments (eCOA), and ePatient solutions, all designed to optimize critical patient engagements. Their cutting-edge software ensures a seamless user experience, facilitating precise randomization, effective drug supply management, and prompt data gathering. Committed to enhancing patient comprehension and reducing the burdens faced by trial sites, Suvoda's solutions are crafted to adapt to the growing intricacies of clinical research. Headquartered near Philadelphia, with additional branches throughout Europe and Asia, Suvoda has proudly aided in the execution of over 1,500 trials across more than 85 countries, demonstrating their extensive global influence and proficiency in the industry. Their unwavering focus on innovation and high standards establishes them as an essential ally in the progress of clinical research, paving the way for future breakthroughs and transformations in the field.

The Medidata Clinical Cloud is an advanced platform crafted to transform the clinical trial experience for patients, sponsors, CROs, and research institutions alike. As the only all-encompassing technological solution dedicated solely to clinical research, this platform covers the entire spectrum of research from its initial stages to final outcomes. It empowers organizations within the life sciences and medical device industries to cut down on development costs, effectively manage risks, and accelerate the launch of new treatments and devices into the market. Regardless of your choice for clinical trial strategies, the advantages of the Medidata Clinical Cloud will be at your disposal. Medidata stands at the leading edge of the digital transformation in clinical research. By harnessing the capabilities of artificial intelligence, machine learning, and advanced analytics, our platform facilitates connections among researchers, study coordinators, investigators, and patients, ultimately speeding up the research process. Furthermore, it features a regulatory-compliant and patient-centric electronic informed consent solution for clinical trials, which improves the experience for everyone involved. This seamless integration of cutting-edge technology not only optimizes operational efficiency but also significantly uplifts the overall quality and integrity of clinical research endeavors. Thus, adopting the Medidata Clinical Cloud means embracing a future where clinical trials are more efficient and patient-focused than ever before.

Zelta serves as a cloud-based platform dedicated to the unified management and acquisition of clinical data, aiming to optimize and improve the processes involved in clinical trials. Its flexible modular structure is tailored to meet the specific requirements of different studies, which leads to quicker and more effective results. With features that include electronic data capture, management of clinical operations—such as randomization and tracking of trial supplies—clinical trial oversight, and electronic trial master file capabilities, Zelta provides thorough supervision of studies. Additionally, it fosters engagement among patients and providers through electronic clinical outcome assessments and e-consent options. Suitable for a range of studies across all phases, therapeutic disciplines, and international locations, Zelta is designed to offer a user-friendly experience with secure single sign-on access available from any location. Its adaptable and scalable framework permits easy customization and seamless integration with both proprietary and third-party technologies, ensuring it can meet various research requirements effectively. This makes Zelta an invaluable tool for researchers looking to streamline their clinical trial efforts.

Manage your clinical trial effortlessly through a unified platform. Zapclinica provides an eClinical suite designed to oversee and execute every aspect of your decentralized clinical trial, whether it is hybrid or fully virtual. By automating complex processes, it aids in identifying discrepancies, maximizing resources, and improving decision-making as well as collaboration among sponsors, CROs, and study sites. This all-encompassing solution dramatically reduces the time and costs involved in conducting a successful clinical trial. With Zapclinica, you can manage all elements of the study without relying on additional vendors or external services; simply choose the essential applications you require within a single cohesive environment, which includes EDC, ETMF, Payments, Logistics, and more. By utilizing this single platform, you can significantly enhance the efficiency of your clinical research endeavors while ensuring that every detail is meticulously handled.

uMotif presents a groundbreaking platform for electronic Clinical Outcome Assessment (eCOA), electronic Patient-Reported Outcomes (ePRO), and electronic consent (eConsent), designed to bolster both clinical and real-world research initiatives. Developed with direct feedback from patients, this platform ensures exceptional engagement, leading to significant enhancements in the efficiency, quality, and accuracy of data gathering. By merging uMotif's eCOA/ePRO system with real-time glucose monitoring, the platform demonstrated impressive compliance rates during an extensive diabetes research project throughout Europe. In a separate case, an immunology trial reaped the benefits of the patient-centric eCOA/ePRO solution, allowing the sponsor to meet data collection targets a remarkable six months earlier than planned. Furthermore, during a CNS study required by the FDA, participants leveraged their own devices to submit ePRO data that was ready for review, illustrating the platform's adaptability. Committed to a patient-first design philosophy, uMotif places a strong emphasis on comprehending the patient experience and the variables that affect their actions. This deep-rooted understanding not only drives the creation of software tailored to patient needs but also achieves exceptionally high levels of engagement for study sponsors, creating a mutually beneficial scenario for all involved. With such innovative features, uMotif is poised to set new standards in the realm of patient-reported outcomes and clinical research methodologies.

We develop cutting-edge solutions designed to improve and fortify the clinical trial landscape. Our Enrollment Performance Management platform is preferred by research sites and trusted by sponsors alike. Currently, it is employed by 2,000 research sites across 26 nations and is endorsed by 50% of the world’s leading biopharmaceutical firms. This system allows sites to minimize the time dedicated to repetitive tasks, resulting in smoother patient transitions. By reducing redundant activities, there is a decrease in the number of logs, calls, and emails needed from both research sites and sponsors. With immediate access to detailed pre-screening and enrollment metrics, sponsors can take proactive measures to enhance enrollment efforts. Our highly intuitive patient recruitment and enrollment solution is relied upon by more than 1,800 sites globally. It offers significant insights into recruitment and enrollment, enabling clinical trials to progress more swiftly and with improved predictability. By cutting out unnecessary tasks, sites can redirect their focus on what is truly important: supporting patients. Effortlessly oversee recruitment across various trials, sponsors, or CROs by entering information just once, ensuring it reaches the appropriate channels. This revolutionary strategy not only simplifies the process but also fosters enhanced collaboration among all parties engaged in clinical trials, ultimately contributing to more efficient research outcomes. With such an innovative approach, we are redefining the standards for success in the clinical trial process.

The Clinion Clinical Trial Management System (CTMS) offers an intuitive interface that integrates effortlessly with Clinion EDC and Clinion RTSM, providing rapid and thorough access to all elements of the trial process, thereby managing critical aspects such as investigator sites, patient enrollment, serious adverse events (SAEs), protocol deviations, participant inclusions, visit scheduling, investigational product (IP) management, key milestones, financial oversight, custom reporting, and real-time analytics, which collectively enhance quality, mitigate risks, and lower expenses. Designed with a modular architecture, Clinion CTMS includes a variety of modules tailored for specific needs, such as the Admin Module, Project Management, Site Monitoring Activities, Finance and Budget Management, Safety Reporting, IP Inventory Management, Document Management System, Audit/Activity Log, and provides comprehensive dashboards and reports to facilitate efficient trial oversight.

In the field of clinical research, meticulous organization is crucial for achieving effective outcomes. The challenge of deploying the right resources at the right time becomes particularly pronounced when it comes to managing documents during a clinical trial. GRAVITY has emerged as a trusted solution for overseeing site files and trial master files. We have reimagined these documents into an accessible and unified electronic format, which significantly improves document management by offering a structured and practical system. Acting as an integrated eTMF and eISF platform, GRAVITY functions as a comprehensive cloud-based Document Management System (DMS), serving as a central hub for sponsors, contract research organizations (CROs), and research sites. Additionally, GRAVITY can be utilized independently by each stakeholder when required. As soon as a site is selected for a clinical trial, there is a surge of incoming documents that need to be managed with precision. GRAVITY incorporates a unique feature that tracks vital document management while alerting users to any documents approaching their expiration dates, thereby promoting compliance and operational efficiency throughout the trial. This forward-thinking strategy not only simplifies processes but also significantly elevates the overall quality of clinical research initiatives. Ultimately, GRAVITY stands as a testament to the advancements in document management technology within the clinical research landscape.

At ePharmaSolutions, we are at the forefront of developing groundbreaking strategies. Although we do not consider ourselves a high-tech corporation, our core is founded on concepts that are intricately linked to technology yet not limited by it. We are transforming the drug development sector by providing solutions that optimize the processes of identifying, activating, training, and managing clinical trial sites. By reinterpreting conventional challenges through a fresh perspective, we deliver technology-enhanced solutions aimed at simplifying the complexities associated with clinical trial management. ePharmaSolutions (ePS) distinguishes itself as a leading provider of e-clinical solutions that revolutionize the processes of selecting, training, activating, and managing clinical trial sites. By introducing innovative viewpoints to persistent challenges, we develop advanced, technology-driven solutions that empower sponsors, contract research organizations, and investigator sites to efficiently tackle and streamline the complexities of clinical trial management. Our dedication to transforming these processes guarantees that we stay at the cutting edge of the industry, consistently evolving to address changing demands, ultimately fostering a more efficient and effective clinical trial landscape.

Mosio empowers research teams to enhance participant engagement, streamline communication, and gather data effectively through the widely used medium of text messaging. Our platform offers research teams the tools to interact more effectively with participants via mobile devices, integrating engaging elements and automated messaging features. WHO CAN BENEFIT? + Sponsors of clinical trials in the pharmaceutical and biotech sectors + Cancer treatment facilities and organizations focused on clinical research + Studies funded by the National Institutes of Health (NIH) + Agencies dedicated to public health + Professionals such as clinical trial managers, directors, project managers, principal investigators, and coordinators, along with all research personnel involved in participant communication. ADVANTAGES + Engaging medication reminders and alerts for compliance + Automation of the data collection process + Boost in participant engagement and adherence rates + SMS reminders for appointments to reduce no-show rates + Improved participant retention through automated check-ins, ensuring ongoing communication and support. Overall, Mosio serves as a vital tool for enhancing the efficiency of clinical research endeavors.

Utilizing actionable insights from a top-tier AI-powered clinical analytics platform empowers your teams to adeptly navigate risks and improve performance across studies, systems, sites, and vendor interactions. The innovative technology developed by Saama is designed to streamline workflows, automate tedious tasks, and enhance collaboration among diverse clinical functions including operations, medical review, data management, biostatistics, and pharmacovigilance. Both sponsors and contract research organizations (CROs) rely on Saama's robust data aggregation and AI capabilities, which support better decision-making, reduce delays, and significantly lower costs and timelines associated with the drug development process. By implementing Saama's solutions, you can hasten the advancement of clinical trial innovation. Centralizing and continuously updating your clinical data greatly simplifies the work of your ClinOps and medical review teams. In addition, Data Managers, who are often overlooked, can redirect their attention from mundane tasks to the essential data points that are critical for project success, thereby ensuring their skills are effectively utilized. This shift not only improves operational efficiency but also plays a vital role in enhancing the quality of clinical outcomes, ultimately contributing to more successful trials and better patient care. Embracing these advancements is imperative for organizations aiming to stay competitive in the ever-evolving landscape of drug development.

Select Curebase for your next research project and benefit from increased diversity, faster enrollment, and better patient retention. Our cutting-edge approach allows patients to engage from their homes with the backing of local physicians, leading to swifter, more affordable, and inclusive research endeavors. The unique synergy between our in-house virtual Clinical Research Coordinators (CRCs) and a global network of virtual Principal Investigators (PIs) ensures that studies are brought directly to patients, regardless of their geographical location. Many individuals live far from traditional research sites; thus, our trials are designed to effectively integrate research into their daily lives and local healthcare settings, such as nearby doctor's offices. Curebase's innovative model for infectious disease studies captivates patients by aligning with their preferences and utilizing both community healthcare and virtual spaces, which broadens participation in critical clinical trials. By harnessing technology and fostering local relationships, Curebase not only increases accessibility but also elevates the entire research experience for both patients and healthcare providers. This commitment to innovation reflects our dedication to transforming the landscape of clinical research for the better.

Explore the latest advancements in collecting clinical and patient-reported outcomes data. Our all-encompassing solution goes beyond simple data recording, aiming to create a truly patient-centered research journey. Our eCOA software, built on the foundations of behavioral science, has been meticulously crafted by healthcare experts to cater to the demands of both research sites and sponsors. By focusing on individual identity, motivational triggers, and key goals, we differentiate ourselves from other eCOA platforms. The Datacubed app is designed with an intuitive interface, enabling participants to easily engage with essential elements. It has been noted that the process of data collection is now more efficient than ever, thanks to our flexible, user-friendly, and interactive application. As the necessity for adaptable trial designs becomes increasingly prominent, we offer a range of versatile data collection methods that can be conducted in-person, remotely, or through a hybrid model, accommodating the varied needs of conventional, hybrid, and virtual clinical studies. This level of flexibility guarantees that researchers can capture the most pertinent data, irrespective of the format of the trial. Furthermore, our commitment to continuous improvement ensures that we remain at the forefront of innovation in the field.